Director Dean C. Kehler Files Intent to Sell Additional Shares Amid Ongoing Distribution
BCIC is trading near its 52-week low of $7.15 (1.0% above the low) on elevated volume (2.7× avg).
Summary
Director Dean C. Kehler intends to sell an additional $273,694 in shares, adding to over $1 million in sales in the past three months, signaling continued insider distribution.
Key Events · Ownership and Investor Activity · BCIC
-
New Intent to Sell
Director Dean C. Kehler, through his revocable trust, has filed a Form 144 to sell 37,100 common shares, valued at approximately $273,694.
-
Ongoing Insider Distribution
This proposed sale follows a series of dispositions by the same director, who has sold a total of 109,651 shares for gross proceeds of over $1 million in the past three months.
-
Stock Trading Near 52-Week Low
The intent to sell comes as the company's stock is trading near its 52-week low of $7.15, potentially amplifying negative investor sentiment.
Analysis · BCIC · Unknown
Director Dean C. Kehler, through his revocable trust, has filed a Form 144 indicating intent to sell an additional $273,694 worth of shares. This filing continues a pattern of significant share dispositions by the director, who has already sold over $1 million in shares in the past three months. The ongoing selling pressure from a director, especially while the stock is trading near its 52-week low, could be interpreted negatively by investors, suggesting a lack of confidence or a need for liquidity.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.4% of the 1637 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BCIC was trading at $7.22 on NASDAQ in the Unknown sector, with a market capitalization of approximately $89.4M. The 52-week trading range was $7.15 to $15.69. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.